The Swedish life science company Cartana, whose technology has its origin in research from Karolinska Institutet and Stockholm University, was recently sold to American 10x Genomics for SEK 424 million. Anders Nordström and Simon Fredriksson have both been involved in the company. We had the opportunity to ask them a few questions about the development of Swedish life science in general, and about Cartana in particular.
